Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which sedation is safer for Kids' MRIs? new study compares two common methods

NCT ID NCT06832683

Symptom relief Sponsor: Kocaeli City Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study compared two sedation methods for children aged 3 months to 10 years undergoing MRI: a combination of propofol and ketamine given through a vein, versus sevoflurane gas given through a face mask. The goal was to see which method allows faster recovery and fewer side effects. The trial involved 230 children and measured recovery time, discharge readiness, and safety issues like low oxygen levels.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
propofol, ketamine, sevoflurane
What this could lead to
If one method proves safer or faster, it could improve sedation practices for children undergoing MRI, reducing risks and recovery time.
What could go wrong
This is a small, completed study with no phase, so results may not apply broadly. Both methods have known side effects like breathing problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

230 people

The number who actually took part.

Started

Jun 2025

Finished

Sep 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 months to 10 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Ages 3 months to 10 years. * Classified as ASA I-II according to the American Society of Anesthesiologists (ASA) classification. * Patients scheduled for MRI at Kocaeli City Hospital MRI unit. Exclusion Criteria: * Families or children who do not consent to participate in the study. * Patients with allergies to ketamine, propofol, midazolam, or sevoflurane. * Patients with known pulmonary or cardiac diseases. * Patients with known congenital craniofacial or neck anomalies. * Patients dependent on oxygen therapy. * Patients with a recent respiratory tract infection within the past 2 weeks. * Patients requiring tracheal intubation, laryngeal mask, or ventilator support. * Patients at risk of upper airway obstruction. * Patients with behavioral problems. * Patients with gastroesophageal reflux disease. * Patients with lethargy, stupor, or unresponsiveness to stimuli due to any cause * Patients with active use of antiepileptic or antipsychotic medications

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypoxemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

follicular lymphoma Hypoxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hypoxemia Patient safety Recovery period

Contacts and locations

Locations

  • Bedirhan Günel

    Kocaeli, İ̇zmi̇t, 41100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.